What is Ohio State University Medical Center Clinical Trial (Pill Form)?

Category: Others

false

Investigators are recruiting 400 people with relapsing-remitting MS for a study evaluating three doses of ACT-128800, an oral compound that affects immune function, versus placebo. The study sponsor is Actelion Pharmaceuticals, Ltd

Last updated:
There are no evaluations for Ohio State University Medical Center Clinical Trial (Pill Form).